Skip to main content

Schonfeld Strategic Advisors LLC

Position in NVAX — Novavax Inc

CIK 1665241 NEW YORK, NY

Position in NVAX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,832,821
+$1,100,930 QoQ
Shares Held
194,567
+116.4% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#48
of 263 holders
Holding Since
Jun 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVAX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. NVAX ranks #55 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVAX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,832,821 194,567
2026-03-31 $731,891 89,913
2025-12-31 $739,435 110,035
2025-09-30 $502,391 57,946
2024-12-31 $219,355 27,283
2024-09-30 $237,810 18,829
2024-06-30 $289,926 22,901
2023-12-31 $49,896 10,395
2023-09-30 $606,284 83,741
2022-12-31 $457,460 44,500
2022-09-30 $3,702,953 203,459
2022-06-30 $3,174,671 61,728
2022-03-31 $2,001,954 27,182
2021-12-31 $940,542 6,574
2021-06-30 $2,738,799 12,900